Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03978793
What this trial is testing

MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users

Who this might be right for
HIV-positive Individuals
Ohio State University 31
Large-scale testing (Phase 3)Study completedNCT01227044
What this trial is testing

Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention

Who this might be right for
Reduction in Heavy Drinking in Patients With HIV
Yale University 51
Post-approval studies (Phase 4)Study completedNCT01222611
What this trial is testing

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Who this might be right for
Chronic HIV InfectionHCV Coinfection
Fundacion SEIMC-GESIDA 42
Post-approval studies (Phase 4)Study completedNCT00724711
What this trial is testing

Safety and Efficacy Study of Switching From Epzicom to Truvada

Who this might be right for
HIV Infection
Gilead Sciences 312
Early research (Phase 1)Study completedNCT01973439
What this trial is testing

PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months

Who this might be right for
HIV Infection
PENTA Foundation 23
Post-approval studies (Phase 4)Enrolling By InvitationNCT06037564
What this trial is testing

B-free Multistage Trial

Who this might be right for
HIVDrug ResistanceDrug Drug Interaction
Insel Gruppe AG, University Hospital Bern 210
Not applicableEnded earlyNCT05219916
What this trial is testing

Selection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses

Who this might be right for
Human Immunodeficiency Virus I Infection
Hospices Civils de Lyon 17
Not applicableStudy completedNCT00084019
What this trial is testing

Atazanavir/Ritonavir Maintenance Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07081763
What this trial is testing

Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control of HIV-1 Replication After Antiretroviral Treatment Interruption

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 191
Post-approval studies (Phase 4)Ended earlyNCT00775606
What this trial is testing

Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease

Who this might be right for
Acquired Immune Deficiency Syndrome
Rush University Medical Center 15
Early research (Phase 1)Looking for participantsNCT07569029
What this trial is testing

A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 42
Post-approval studies (Phase 4)Study completedNCT00626301
What this trial is testing

Lopinavir/Ritonavir Monotherapy in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 40
Testing effectiveness (Phase 2)Study completedNCT01565850
What this trial is testing

D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 153
Not applicableStudy completedNCT03394391
What this trial is testing

The Effectiveness of SMS in Improving Antiretroviral Medication Adherence Among Adolescents Living With HIV in Nigeria

Who this might be right for
HIV Infections
Dr. Olumide ABIODUN 212
Not applicableStudy completedNCT04170374
What this trial is testing

Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-South Africa

Who this might be right for
HIVAntiretroviral Therapy
Boston University 831
Not applicableWithdrawnNCT00051090
What this trial is testing

Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV

Who this might be right for
HIV InfectionsHepatitis B
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT00099359
What this trial is testing

Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission

Who this might be right for
Disease Transmission, VerticalVertical Human Immunodeficiency Virus TransmissionHIV Infections
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1,735
Not applicableStudy completedNCT01610427
What this trial is testing

Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects

Who this might be right for
AIDSAIDS Vaccines
GlaxoSmithKline 22
Early research (Phase 1)Ended earlyNCT03705169
What this trial is testing

Pharmacokinetics and Safety of SAR441236

Who this might be right for
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID) 52
Testing effectiveness (Phase 2)Study completedNCT00002440
What this trial is testing

1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 80
Next Page